Evidence map›Paper›PMID 30061108›Full record

ArticleThe Journal of cell biology2018

A NUMB-EFA6B-ARF6 recycling route controls apically restricted cell protrusions and mesenchymal motility.

Martina Zobel, Andrea Disanza, Francesca Senic-Matuglia, Michel Franco, Ivan Nicola Colaluca, Stefano Confalonieri, Sara Bisi, Elisa Barbieri, Giusi Caldieri, Sara Sigismund and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Recycling Endosome in Nerve Cell Development: One Rab to Rule Them All?Frontiers in cell and developmental biology · 2020
    Review
  11. Review
  12. Exon 3 of theG3 (Bethesda, Md.) · 2019
    Article
  13. Is cell migration a selectable trait in the natural evolution of cancer development?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Martina ZobelIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Andrea DisanzaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Francesca Senic-MatugliaDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.ORCID 0000-0002-1883-9424
Michel FrancoUniversité Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0000-0003-1853-8661
Ivan Nicola ColalucaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0002-3371-112X
Stefano ConfalonieriIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0001-6886-9851
Sara BisiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Elisa BarbieriDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Giusi CaldieriDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Sara SigismundDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.ORCID 0000-0002-1396-4453
Salvatore PeceDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Philippe ChavrierInstitut Curie, PSL Research University, Paris, France.ORCID 0000-0002-7351-733X
Pier Paolo Di FioreIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy pierpaolo.difiore@ieo.it.ORCID 0000-0002-2252-0950
Giorgio ScitaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy giorgio.scita@ifom.eu.ORCID 0000-0001-7984-1889
IFOM · ITUniversity of Milan · ITEuropean Institute of Oncology · ITCentre National de la Recherche Scientifique · FRInstitut de Pharmacologie Moléculaire et Cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endocytic protein NUMB has been implicated in the control of various polarized cellular processes, including the acquisition of mesenchymal migratory traits through molecular mechanisms that have only been partially defined. Here, we report that NUMB is a negative regulator of a specialized set of understudied, apically restricted, actin-based protrusions, the circular dorsal ruffles (CDRs), induced by either PDGF or HGF stimulation. Through its PTB domain, NUMB binds directly to an N-terminal NPLF motif of the ARF6 guanine nucleotide exchange factor, EFA6B, and promotes its exchange activity in vitro. In cells, a NUMB-EFA6B-ARF6 axis regulates the recycling of the actin regulatory cargo RAC1 and is critical for the formation of CDRs that mark the acquisition of a mesenchymal mode of motility. Consistently, loss of NUMB promotes HGF-induced cell migration and invasion. Thus, NUMB negatively controls membrane protrusions and the acquisition of mesenchymal migratory traits by modulating EFA6B-ARF6 activity.

Indexed as

ADP-Ribosylation Factor 6ADP-Ribosylation FactorsCell Line, TumorCell MovementCell PolarityGuanine Nucleotide Exchange FactorsHeLa CellsHepatocyte Growth FactorHumansMembrane ProteinsMesodermNerve Tissue ProteinsPlatelet-Derived Growth FactorProtein BindingProtein Domainsrac1 GTP-Binding ProteinADP-Ribosylation Factor 6ADP-Ribosylation FactorsARF6 protein, humanGuanine Nucleotide Exchange FactorsHepatocyte Growth FactorHGF protein, humanMembrane ProteinsNerve Tissue ProteinsNUMB protein, humanPlatelet-Derived Growth FactorPSD4 protein, humanrac1 GTP-Binding ProteinRAC1 protein, humanRNA, Small Interfering

Identifiers

PMID30061108
PMCPMC6123001
OpenAlexW2885335886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.